- Home
- Publications
- Publication Search
- Publication Details
Title
Neuroprotective Effects of Angiotensin Receptor Blockers
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF HYPERTENSION
Volume 28, Issue 3, Pages 289-299
Publisher
Oxford University Press (OUP)
Online
2014-11-01
DOI
10.1093/ajh/hpu197
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals
- (2016) JOURNAL OF HYPERTENSION
- The role of inflammasome in Alzheimer's disease
- (2014) Li Liu et al. AGEING RESEARCH REVIEWS
- Impaired Renal Function and Biomarkers of Vascular Disease in Alzheimer’s Disease
- (2014) Cassandra Richardson et al. Current Alzheimer Research
- Antihypertensive drug Valsartan promotes dendritic spine density by altering AMPA receptor trafficking
- (2013) Young In Sohn et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Role of the peroxisome proliferator-activated receptors (PPAR)-α, β/δ and γ triad in regulation of reactive oxygen species signaling in brain
- (2013) Stepan Aleshin et al. BIOLOGICAL CHEMISTRY
- Angiotensin Type 1 Receptor Inhibition Enhances the Extinction of Fear Memory
- (2013) Paul J. Marvar et al. BIOLOGICAL PSYCHIATRY
- An evolving story of angiotensin-II-forming pathways in rodents and humans
- (2013) Carlos Maria Ferrario et al. CLINICAL SCIENCE
- Class- and Molecule-specific Differential Effects of Angiotensin II Type 1 Receptor Blockers
- (2013) Satoshi Imaizumi et al. CURRENT PHARMACEUTICAL DESIGN
- Do Angiotensin Receptor Blockers Protect Against Alzheimer’s Disease?
- (2013) Hitomi Kurinami et al. DRUGS & AGING
- Antihypertensive Therapy and Cerebral Hemodynamics in Executive Mild Cognitive Impairment: Results of a Pilot Randomized Clinical Trial
- (2013) Ihab Hajjar et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Cognitive Disorders and Dementia in CKD: The Neglected Kidney-Brain Axis
- (2013) J.-M. Bugnicourt et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Development, maintenance and disruption of the blood-brain barrier
- (2013) Birgit Obermeier et al. NATURE MEDICINE
- The Pathobiology of Vascular Dementia
- (2013) Costantino Iadecola NEURON
- Effect of chronic treatment with angiotensin type 1 receptor antagonists on striatal dopamine levels in normal rats and in a rat model of Parkinson's disease treated with l-DOPA
- (2013) Antonio Dominguez-Meijide et al. NEUROPHARMACOLOGY
- Telmisartan ameliorates glutamate-induced neurotoxicity: Roles of AT1 receptor blockade and PPARγ activation
- (2013) Juan Wang et al. NEUROPHARMACOLOGY
- Do Angiotensin Receptor Blockers Really Hold Promise for the Improvement of Cognitive Functioning?
- (2012) Chittaranjan Andrade et al. ARCHIVES OF INTERNAL MEDICINE
- (Pro)renin and its receptors: pathophysiological implications
- (2012) Wendy W. Batenburg et al. CLINICAL SCIENCE
- Regulation of angiotensin II receptors beyond the classical pathway
- (2012) Masatsugu Horiuchi et al. CLINICAL SCIENCE
- Angiotensin II AT1receptor blockers as treatments for inflammatory brain disorders
- (2012) Juan M. Saavedra CLINICAL SCIENCE
- The intracrine renin–angiotensin system
- (2012) Rajesh Kumar et al. CLINICAL SCIENCE
- Telmisartan Improves Insulin Resistance of Skeletal Muscle Through Peroxisome Proliferator-Activated Receptor- Activation
- (2012) L. Li et al. DIABETES
- Peroxisome Proliferator-Activated Receptor-γ Activation With Angiotensin II Type 1 Receptor Blockade Is Pivotal for the Prevention of Blood-Brain Barrier Impairment and Cognitive Decline in Type 2 Diabetic Mice
- (2012) Li-Juan Min et al. HYPERTENSION
- The Renin-Angiotensin Pathway in Posttraumatic Stress Disorder
- (2012) Nayla M. Khoury et al. JOURNAL OF CLINICAL PSYCHIATRY
- Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease
- (2012) Pablo Garrido-Gil et al. Journal of Neuroinflammation
- Telmisartan directly ameliorates the neuronal inflammatory response to IL-1β partly through the JNK/c-Jun and NADPH oxidase pathways
- (2012) Tao Pang et al. Journal of Neuroinflammation
- MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles
- (2012) Eva van Rooij et al. NATURE REVIEWS DRUG DISCOVERY
- Candesartan, an Angiotensin II AT1-Receptor Blocker and PPAR-γ Agonist, Reduces Lesion Volume and Improves Motor and Memory Function After Traumatic Brain Injury in Mice
- (2012) Sonia Villapol et al. NEUROPSYCHOPHARMACOLOGY
- Whole-body distribution and radiation dosimetry of [11C]telmisartan as a biomarker for hepatic organic anion transporting polypeptide (OATP) 1B3
- (2012) Keiji Shimizu et al. NUCLEAR MEDICINE AND BIOLOGY
- Brain penetration of telmisartan, a unique centrally acting angiotensin II type 1 receptor blocker, studied by PET in conscious rhesus macaques
- (2012) Akihiro Noda et al. NUCLEAR MEDICINE AND BIOLOGY
- Role of central angiotensin receptors in scopolamine-induced impairment in memory, cerebral blood flow, and cholinergic function
- (2012) Santoshkumar Tota et al. PSYCHOPHARMACOLOGY
- Roles of Brain Angiotensin II in Cognitive Function and Dementia
- (2012) Masaki Mogi et al. International Journal of Hypertension
- Mitochondrial oxidative stress mediates induction of autophagy and hypertrophy in angiotensin-II treated mouse hearts
- (2011) Dao-Fu Dai et al. Autophagy
- Telmisartan protects against diabetic vascular complications in a mouse model of obesity and type 2 diabetes, partially through peroxisome proliferator activated receptor-γ-dependent activity
- (2011) Kensuke Toyama et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Angiotensin II AT1 Receptor Blockers Ameliorate Inflammatory Stress: A Beneficial Effect for the Treatment of Brain Disorders
- (2011) Juan M. Saavedra CELLULAR AND MOLECULAR NEUROBIOLOGY
- Exploring the potential of telmisartan in chronic constriction injury-induced neuropathic pain in rats
- (2011) Amteshwar Singh Jaggi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Telmisartan ameliorates lipopolysaccharide-induced innate immune response through peroxisome proliferator-activated receptor-γ activation in human monocytes
- (2011) Tao Pang et al. JOURNAL OF HYPERTENSION
- Blockade of AT1 Receptors Protects the Blood-Brain Barrier and Improves Cognition in Dahl Salt-Sensitive Hypertensive Rats
- (2010) N. Pelisch et al. AMERICAN JOURNAL OF HYPERTENSION
- Chronic AT1 receptor blockade normalizes NMDA-mediated changes in renal sympathetic nerve activity and NR1 expression within the PVN in rats with heart failure
- (2010) Allison C. Kleiber et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Tissue Renin-Angiotensin-Aldosterone Systems: Targets for Pharmacological Therapy
- (2010) Michael Bader Annual Review of Pharmacology and Toxicology
- Irbesartan treatment up-regulates hepatic expression of PPARα and its target genes in obese Koletsky (fak/fak) rats: a link to amelioration of hypertriglyceridaemia
- (2010) X Rong et al. BRITISH JOURNAL OF PHARMACOLOGY
- Role of angiotensin II receptor subtype activation in cognitive function and ischaemic brain damage
- (2010) Masatsugu Horiuchi et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pleiotropic Effects of Inhibitors of the RAAS in the Diabetic Population: Above and Beyond Blood Pressure Lowering
- (2010) Haisam Ismail et al. Current Diabetes Reports
- Angiotensin II type 1 receptor-independent beneficial effects of telmisartan on dietary-induced obesity, insulin resistance and fatty liver in mice
- (2010) X. Rong et al. DIABETOLOGIA
- Telmisartan Prevents Weight Gain and Obesity Through Activation of Peroxisome Proliferator-Activated Receptor-δ–Dependent Pathways
- (2010) Hongbo He et al. HYPERTENSION
- Losartan inhibits LPS-induced inflammatory signaling through a PPARγ-dependent mechanism in human THP-1 macrophages
- (2010) Jianbo An et al. HYPERTENSION RESEARCH
- Angiotensin II sustains brain inflammation in mice via TGF-β
- (2010) Tobias V. Lanz et al. JOURNAL OF CLINICAL INVESTIGATION
- Benefits of Prestroke Use of Angiotensin Type 1 Receptor Blockers on Ischemic Stroke Severity
- (2010) Nobukazu Miyamoto et al. Journal of Stroke & Cerebrovascular Diseases
- Angiotensin II AT1 Receptor Blockade Ameliorates Brain Inflammation
- (2010) Julius Benicky et al. NEUROPSYCHOPHARMACOLOGY
- Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications
- (2010) Juan M. Saavedra et al. PSYCHONEUROENDOCRINOLOGY
- Protective Effects of Intranasal Losartan in the APP/PS1 Transgenic Mouse Model of Alzheimer Disease
- (2010) Lusine Danielyan et al. REJUVENATION RESEARCH
- Angiotensin II AT1 blockade reduces the lipopolysaccharide-induced innate immune response in rat spleen
- (2009) Enrique Sánchez-Lemus et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Parkinson's Disease
- (2009) Christopher H. Hawkes et al. Annals of the New York Academy of Sciences
- Molecular mechanisms of the antagonistic action between AT1 and AT2 receptors
- (2009) Shin-ichiro Miura et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Anti-Inflammatory Effects of Angiotensin Receptor Blockers in the Brain and the Periphery
- (2009) Julius Benicky et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Cognitive Deficit in Amyloid-β–Injected Mice Was Improved by Pretreatment With a Low Dose of Telmisartan Partly Because of Peroxisome Proliferator-Activated Receptor-γ Activation
- (2009) Kana Tsukuda et al. HYPERTENSION
- Telmisartan inhibits cytokine-induced nuclear factor-κB activation independently of the peroxisome proliferator-activated receptor-γ
- (2009) Ayuko Nakano et al. HYPERTENSION RESEARCH
- Angiotensin receptors as determinants of life span
- (2009) Paola Cassis et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Anti-atherosclerotic properties of telmisartan in advanced atherosclerotic lesions in apolipoprotein E deficient mice
- (2008) Erwin Blessing et al. ATHEROSCLEROSIS
- Candesartan improves memory decline in mice: Involvement of AT1 receptors in memory deficit induced by intracerebral streptozotocin
- (2008) Santoshkumar Tota et al. BEHAVIOURAL BRAIN RESEARCH
- Telmisartan prevented cognitive decline partly due to PPAR-γ activation
- (2008) Masaki Mogi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The AT1 Receptor Antagonist, L-158,809, Prevents or Ameliorates Fractionated Whole-Brain Irradiation–Induced Cognitive Impairment
- (2008) Mike E. Robbins et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Evaluation of Direct Transport Pathways of Glycine Receptor Antagonists and an Angiotensin Antagonist from the Nasal Cavity to the Central Nervous System in the Rat Model
- (2008) Stuart T. Charlton et al. PHARMACEUTICAL RESEARCH
- Telmisartan Inhibits Advanced Glycation End Products (AGEs)-Elicited Endothelial Cell Injury by Suppressing AGE Receptor (RAGE) Expression Via Peroxisome Proliferator-Activated Receptor-γ Activation
- (2008) Sho-ichi Yamagishi et al. PROTEIN AND PEPTIDE LETTERS
- Anti-inflammatory and anti-oxidant properties of telmisartan in cultured human umbilical vein endothelial cells
- (2007) Silvana Cianchetti et al. ATHEROSCLEROSIS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now